[
  {
    "ts": null,
    "headline": "Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer",
    "summary": "UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate Aurora Research Institute, has received a $75,000 matching grant from the Wisconsin Economic Development Corporation (WEDC) in partnership with the University of Wisconsin. The grant supplements the company's $500,000 SBIR Phase I Fast Track award from the National Institutes of Health (NIH), received last year.",
    "url": "https://finnhub.io/api/news?id=829a416e834ff4821d61456e2630e5f12bfe099990b50152977539f628ffcd1a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750860900,
      "headline": "Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer",
      "id": 135532053,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate Aurora Research Institute, has received a $75,000 matching grant from the Wisconsin Economic Development Corporation (WEDC) in partnership with the University of Wisconsin. The grant supplements the company's $500,000 SBIR Phase I Fast Track award from the National Institutes of Health (NIH), received last year.",
      "url": "https://finnhub.io/api/news?id=829a416e834ff4821d61456e2630e5f12bfe099990b50152977539f628ffcd1a"
    }
  },
  {
    "ts": null,
    "headline": "Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer",
    "summary": "The global elahere market is set for rapid growth, projected to surge to $6.07 billion by 2034 at a CAGR of 28.68%. Key growth drivers include rising ovarian cancer prevalence, healthcare access in emerging markets, and increased demand for personalized medicine. Despite challenges like high costs and competition, the market, led by AbbVie Inc. (ImmunoGen), presents vast opportunities, particularly in online pharmacies and hospital segments. The fastest growth will occur in Western and Eastern E",
    "url": "https://finnhub.io/api/news?id=a6c4292633763c986c7bdd2d9449ce6b028ba26832ff473f2afc90e34603cb01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750856280,
      "headline": "Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer",
      "id": 135532054,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The global elahere market is set for rapid growth, projected to surge to $6.07 billion by 2034 at a CAGR of 28.68%. Key growth drivers include rising ovarian cancer prevalence, healthcare access in emerging markets, and increased demand for personalized medicine. Despite challenges like high costs and competition, the market, led by AbbVie Inc. (ImmunoGen), presents vast opportunities, particularly in online pharmacies and hospital segments. The fastest growth will occur in Western and Eastern E",
      "url": "https://finnhub.io/api/news?id=a6c4292633763c986c7bdd2d9449ce6b028ba26832ff473f2afc90e34603cb01"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys",
    "summary": "Explore May 2025 market volatility, U.S.-China trade talks, and record dividend income growth.",
    "url": "https://finnhub.io/api/news?id=28d3b832c1fca31770119594903f09760ded636b8898fcc7533e46ddeeaa3cac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750839000,
      "headline": "My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys",
      "id": 135524419,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Explore May 2025 market volatility, U.S.-China trade talks, and record dividend income growth.",
      "url": "https://finnhub.io/api/news?id=28d3b832c1fca31770119594903f09760ded636b8898fcc7533e46ddeeaa3cac"
    }
  }
]